icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 13 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

LECANEMAB

Brand name
LECANEMAB Leqembi
المخاطر

To remind healthcare professionals in Saudi Arabia of the following:
• Potential risk of death associated with Amyloid-Related Imaging Abnormalities with Edema (ARIA-E) linked to Lecanemab.
• To remind HCPs and patients on the approved Risk minimization measures to minimize this risks of: ( ARIA-E/vasogenic cerebral oedema , ARIA-H (cerebral microhaemorrhage and superficial siderosis ) AND ARIA intracerebral haemorrhage >1 cm in Diameter.
• To inform that local product information has been updated to magnetic resonance imaging (MRI) schedule to include an additional  MRI scan prior to the third infusion of LEQEMBI to identify ARIA-E at an early stage.

تاريخ الموافقة
Educational materials for healthcare practitioners
Messages directed to healthcare practitioners
المواد التعليمية الموجهة للمريض